Study types
- article 3
- other 1
- preprint 1
Condition tags
- adenomyosis 3
- endometriosis 2
Top journals
Frequent coauthors
- Wei Shi 3
- Zhi-Yong Liu 2
- Xin Wang 2
- Ya-Xin Shi 2
- Yiran Zhang 2
- Yang Liu 2
- Li Xu 2
- Guojing Li 1
- Fengxin Cui 1
- Cheng-Yuan Zhang 1
other
2026
article
2025
BACKGROUND AND PURPOSE: Chinese patent medicines (CPMs), standardized herbal formulations widely used in clinical practice, combined with hormones have shown favorable therapeutic effects in the adjuvant treatment of endometriosis (EMS) aft…
article
2024
BACKGROUND: The active ingredients of the Chinese medical herb Paris polyphylla, P. polyphylla ethanol extract (PPE) and polyphyllin I (PPI), potentially inhibit epithelial-mesenchymal transition (EMT) in tumors. However, the roles of these…
article
2022
OBJECTIVE: To explore the molecular mechanism of the Cinnamomi ramulus and Paris polyphylla Sm. (C-P) drug pair in the treatment of adenomyosis (AM) based on network pharmacology and animal experiments. METHODS: Via a network pharmacology …
preprint
2022
Some of the key steps in adenomyosis (AM) are the migration and invasion of adenomyosis derived cells (AMDC); these processes require rearrangement of the cytoskeleton which Rho/ROCK signaling pathway is involved. The aim of the current stu…